article thumbnail

FDA-Approved Labeling: Is Enough Enough?

FDA Law Blog

Interestingly, the Plaintiffs alleged that this duty existed when the mother was pregnant in 2015 even though the studies relied upon in the litigation are from 2021. This is because the presumption that manufacturers can unilaterally make substantive changes to the labeling of an OTC Monograph drug product is false. But we digress.

article thumbnail

Gabapentinoids – Gabapentin and Pregabalin: Tasce Bongiovanni, Donovan Maust and Nisha Iyer

GeriPal

By 2015 that number increased to 4% of US adults. And for that reason, there was actually an enormous lawsuit, and the manufacturer was fined, now I think 20 years ago, in the millions and millions of dollars for off-label prescribing. In 2002, 1% of adults were taking gabapentinoids (gabapentin and or pregabalin).

article thumbnail

Aging and Climate Change: Karl Pillemer, Leslie Wharton, & Ruth McDermott-Levy

GeriPal

And we have gone from 250 members at the end of 2015 to about 26,000 right now across the United States and a number of chapters that have grown. Eric: So as we start talking about things that we can do about it, maybe we can just start off with this thing of including it in the curriculum for healthcare professionals.